Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Contact Simona Malucchi

From: Rituximab suppresses disease activity after natalizumab withdrawal: an exploratory study

Contact corresponding author